(Q22251077)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

cerebral amyloid angiopathy

23 February 2020

main subject

pathology

0 references

1 reference

Erratum: Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy

inferred from title

corrigendum / erratum

0 references

3

Matthew Ellis

Matthew

Ellis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

4

Jonathan D F Wadsworth

Jonathan D F

Wadsworth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6

Joanna Kenny

Joanna

Kenny

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

8

Jacqueline Linehan

Jacqueline

Linehan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

12

John

Collinge

John Collinge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Zane Jaunmuktane

1

Zane

Jaunmuktane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Simon Mead

2

Simon

Mead

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Francesca Launchbury

7

Francesca

Launchbury

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Angela Richard-Loendt

9

Angela

Richard-Loendt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Peter Rudge

11

Peter

Rudge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sebastian Brandner

13

Sebastian

Brandner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Andrew J Nicoll

5

Andrew J

Nicoll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Sarah Walker

10

A Sarah

Walker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

number of pages

4

1 reference

inferred from page(s)

published in

Nature

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

7568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

247-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Iatrogenic Creutzfeldt-Jakob disease, final assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Prion diseases of humans and animals: their causes and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Kuru in the 21st century--an acquired human prion disease with very long incubation periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

A general model of prion strains and their pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Risk factors and preventive interventions for Alzheimer disease: state of the science

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Alzheimer's disease and history of blood transfusion by apolipoprotein-E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Aβ seeds resist inactivation by formaldehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Validation of next-generation sequencing technologies in genetic diagnosis of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Molecular diagnosis of human prion disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE15369

PrP glycoforms are associated in a strain-specific ratio in native PrPSc

21 January 2018

1 reference

12 December 2020

Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.

1 reference

12 December 2020

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): clinical, neuropsychological, and neuropathological components

1 reference

12 December 2020

Hue-saturation-density (HSD) model for stain recognition in digital images from transmitted light microscopy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NATURE15369

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 February 2020

1010914209

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26354483%20AND%20SRC:MED&resulttype=core&format=json